- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Strides Pharma Science Ltd (SRID)
The Strides Pharma share price today is 1,082.20, view NSE SRID stock exchange data. Track the latest Strides Pharma share price with real-time updates on SRID stock performance including market cap, day range, 52-week range and dividend yield. Access SRID charts, earnings dates and analyst estimates to support your investment decisions.
1,082.20
-29.10(-2.62%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,072.00
1,121.00
52 wk Range
768.65
1,231.00
SRID is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,072.001,121.00
52 wk Range
768.651,231.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.36%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.36%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SRID Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
1,261.00
Upside
+16.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,261.00
(+16.52% Upside)
Earnings
Latest Release
18-05-2026
EPS / Forecast
13.77 / --
Revenue / Forecast
13.24B / --
Compare SRID to Peers and Sector
Metrics to compare | SRID | Peers Peers - average of corresponding metrics from companies closely matching SRID: GRANULES, JUBLPHARMA, AUROPHARMA, ZYDUSLIFE, AJANTPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSRIDPeersSector |
|---|---|---|---|---|
P/E Ratio | 17.9x | 28.2x | −0.4x | |
PEG Ratio | −0.21 | 0.83 | 0.00 | |
Price/Book | 3.2x | 3.9x | 2.6x | |
Price / LTM Sales | 2.0x | 3.9x | 3.0x | |
Upside (Analyst Target) | 15.9% | 5.3% | 56.2% | |
Fair Value Upside | Unlock | 6.7% | 8.9% | Unlock |
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. The company was incorporated in 1990 and is based in Bengaluru, India.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Strides Pharma (SRID) Share Price Today?
The Strides Pharma share price today is 1,082.20.
What is the current Strides Pharma (SRID) share price and day range?
As of 26-06-2026, the Strides Pharma share price is 1,082.20, with a previous close of 1,111.30. The share price has ranged from 1,072.00 to 1,121.00 today, while the 52-week range spans from 768.65 to 1,231.00.
What Is the Strides Pharma Market Cap?
As of today, Strides Pharma market cap is 99.75B.
Does Strides Pharma Pay Dividends? What's The Current Dividend Yield?
The Strides Pharma dividend yield is 0.36%.
What Is the Strides Pharma (SRID) Share Price Target?
The average 12-month share price target for Strides Pharma is 1,261.00, with a high estimate of 1410 and a low estimate of 1119. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +16.52% Upside potential.
What Is Strides Pharma's Earnings Per Share (TTM)?
The Strides Pharma EPS (TTM) is 60.34.
When Is the Next Strides Pharma Earnings Date?
Strides Pharma will release its next earnings report on 05-08-2026.
From a Technical Analysis Perspective, Is SRID a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
What Stock Exchange Does Strides Pharma Trade On?
Strides Pharma is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Strides Pharma?
The stock symbol for Strides Pharma is "SRID."
How Many Times Has Strides Pharma Stock Split?
Strides Pharma has split 0 times.
How Many Employees Does Strides Pharma Have?
Strides Pharma has 3301 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.